A. ONE-DOSE ANALYSIS A-1. VACCINE EFFECTIVENESS [95% Confidence Intervals] | |||||||||
Author, year of epidemic (ref) | Casesa | Â | Age at first vaccination | ||||||
< 9 | 9 | 10–11 | 12 | 13–14 | 15 | > 15 | |||
McIntyre, 1977 [31] | 65 |  |  |  |  | 100% [−] | 75.2% [47, 96] | 93.3% [87, 97] | |
Aaby, 1980 [32] | 49 | Â | 54.1% [5, 78] | 48.6% [0, 76] | 69.8% [49, 82] | ||||
Hull, 1981 [33] | 61 | Â | 41.9% [0, 76] | 85.5% [56, 95] | 85.9% [45, 96] | 90.2% [78, 96] | |||
Anonymus, 1983 [34] | 264 | Â | 43.0% [NC] | 83.0% [NC] | |||||
Nkowane, 1984 [35] | 18 | Â | 33.3% [0, 83] | 98.0% [82, 100] | 93.2% [78, 98] | ||||
McCombie, 1985 [36] | 83 |  | −87.9% [− 438, 34] | 33.0% [0, 73] | 51.0% [0, 79] | ||||
Davis, 1985 [37] | 25 |  | 100% [−] | 97.5% [91, 99] | 96.8% [83, 99] | ||||
Roberston, 1986 [38] | 40 | Â | 70.2% [22, 80] | 84.0% [63, 93] | 95.1% [88, 98] | ||||
George, 1986 [39] | 67 | Â | 50.3% [22, 68] | 59.0% [36, 74] | Â | Â | Â | Â | |
Sharma 1987 [40] | 132 |  |  | 49.7% [22, 68] | 52.7% [23, 71] | 71.0% [0–96] | 73.4% [0, 96] | ||
Hersh, 1987 [41] | 46 | Â | 80.8% [39, 94] | 80.5% [51, 92] | 93.7% [84, 97] | ||||
Lee, 1988 [42] | 52 |  | 79.5% [0–97] | 75.4% [3, 94] | 78.9 [61, 88] | ||||
Chawla, 1989 [3] | 176 |  |  | 77.3% [53, 89] | 87.7% [67, 95] | 100% [−] | |||
Rivest, 1989 [4] | 138 | Â | Â | Â | 87.2% [0, 99] | 91.5%[0, 100] | 96.5% [37, 100] | 97.8% [60, 100] | |
De la Puente,1990 [43] | 50 | Â | Â | Â | Â | 58.5% [13, 80] | 70.5% [59, 79] | ||
Malfait, 1990 [44] | 94 | Â | Â | 25.9% [8, 41] | 94.4% [93, 96] | ||||
Murray, 1990 [5] | 74 | Â | 40.1% [0, 81] | 75.5% [47, 89] | 86.9% [66, 95] | 92.0% [75, 97] | |||
Coetzee, 1992 [45] | 17 |  | 74.7% [13, 93] | 81.4% [51–93] | |||||
McDonnell,1993 [46] | 40 | Â | 96.6% [66, 100] | 95.7% [84, 99] | 95.0% [84, 98] | ||||
Lee, 1994 [47] | 6 |  | 30.0% [0, 87] | 72.0% [0, 95] | 100% [−] | ||||
Kaninda, 1995 [48] | 1295 | Â | 86.9% [81, 91] | 94.2% [93, 95] | |||||
Kotb, 1995 [49] | 230 | Â | Â | 25.6%[0, 53] | 72.3% [55, 83] | ||||
Hennessey, 1996 [50] | 167 |  | 91.5% [67, 98] | 87.9% [83–92] | 91.0% [87, 94] | 90.0 [84, 94] | |||
John, 1999 [51] | 67 | Â | 24.0% [0, 55] | 62.2% [0, 87] | |||||
A-2. MEASLES RISK RATIO / ODDS RATIO [95% Confidence Intervals] | |||||||||
Author, year of epidemic (ref) | Casesa | RR/ORb | Age at first vaccination | ||||||
< 9 | 9 | 10–11 | 12 | 13–14 | 15 | > 15 | |||
Shelton, 1976 [52] | 21 | OR | 1.00 [0.2, 4.7] | 1.00 (ref) | 0.05 [0.01, 0.3] | ||||
Judelsohn, 1978 [53] | 58 | RR | 1.92 [0.7, 5.3] | 0.49 [0.2, 1.1] | 1.00 (ref) | 0.34 [0.1, 0.8] | 0.48 [0.3, 0.9] | ||
Faust, 1978 [54] | 63 | RR | 0.92 [0.5, 1.6] | 1.00 (ref) | 0.26 [0.1, 0.6] | 0.44 [0.1, 1.4] | 0.25 [0.1, 0.7] | ||
Lopes, ≈1979 [55] | 14 | RR | 1.62 [0.7, 3.6] | 1.00 (ref) | |||||
Aaby, 1980 [32] | 49 | RR | 1.52 [0.6, 3.6] | 1.70 [0.7, 4.2] | 1.00 (ref) | ||||
Hull, 1981 [33] | 61 | RR | 4.13 [0.8, 20.2] | 1.03 [0.2, 5.8] | 1.00 (ref) | 0.69 [0.2, 3.3] | |||
Wassilak, 1981 [56] | 18 | OR | 1.00 [0.1, 8.4] | 1.00 (ref) | 0.20 [0.02, 2.0] | 0.11 [0.03, 0.4] | |||
Hull, 1984 [57] | 21 | OR | NC | 1.00 (ref) | 0.21 [0.1, 0.9] | ||||
Nkowane, 1984 [35] | 18 | RR | 32.92 [3.8, 283.5] | 1.00 (ref) | 3.31 [0.4, 25.7] | ||||
McCombie, 1985 [36] | 83 | RR | 2.80 [1.2, 6.4] | 1.00 (ref) | 0.73 [0.4, 1.2] | ||||
Davis, 1985 [37] | 25 | RR | 0 | 1.00 (ref) | 1.30 [0.4, 4.4] | ||||
Chen, 1985 [58] | 16 | OR | 1.20 [0.2, 7.3] | 1.00 (ref) | 0.14 [0.03, 0.6] | ||||
Mast, 1986 [59] | 170 | OR | 3.09 [0.9, 1.08] | 1.00 (ref) | 0.15 [0.1, 0.3] | ||||
Roberston, 1986 [38] | 40 | RR | 1.86 [0.9, 3.9] | 1.00 (ref) | 0.31 [0.2, 0.7] | ||||
Sharma 1987 [40] | 132 | RR | Â | 1.06 [0.6, 2.0] | 1.00 (ref) | 0.61[0.1, 4.2] | 0.56 [0.1, 3.9] | ||
Hutchins, 1987 [60] | 30 | RR | Â | Â | Â | 1.00 (ref) | 0.49 [0.1, 1.8] | 0.60 [0.3, 1.3] | |
Hersh, 1987 [41] | 46 | RR | 0.99 [0.4, 2.6] | 1.00 (ref) | 0.32 [0.2, 0.6] | ||||
Agocs, 1988 [61] | 79 | RR | 1.00 (ref) | 0.92 [0.6, 1.4] | |||||
Lee, 1988 [42] | 52 | RR | 1.00 (ref) | 1.20 [0.1, 12.4] | 1.03 [0.1, 7.5] | ||||
Paunio, 1988 [10] | 153c | OR | 1.00 (ref) | 0.37 [0.1, 1.0] | |||||
Chawla, 1989 [3] | 176 | RR | Â | 1.84 [0.6, 6.1] | 1.00 (ref) | 0.00 | |||
Ng, 1989 [62] | 16 | RR | 1.70 [0.4, 7.2] | 1.00 (ref) | 0.41 [0.1, 3.1] | ||||
De Serres, 1989 [63] | 525 | OR | 0.98 [0.7, 1.4] | 1.00 (ref) | 0.50 [0.4, 0.7] | 0.29 [0.2, 0.4] | |||
Rivest, 1989 [4] | 138 | OR | Â | Â | 1.56 [0.5, 4.5] | 1.00 (ref) | 0.40 [0.2, 0.8] | 0.26 [0.2, 0.5] | |
De la Puente, 1990 [43] | 50 | RR | Â | Â | Â | 1.00 (ref) | 0.71 [0.3, 1.7] | ||
Malfait, 1990 [44] | 94 | RR | Â | 13.23 [6.4, 26.5] | 1.00 (ref) | ||||
De Serres, 1990 [64] | 5514 | OR | Â | Â | 1.40 [1.2, 1.6] | 1.00 (ref) | 0.59 [0.5, 0.6] | 0.38 [0.3, 0.4] | 0.38 [0.3, 0.4] |
Murray, 1990 [5] | 74 | RR | 4.58 [1.1, 20.0] | 1.88 [0.6, 6.2] | 1.00 (ref) | 0.62 [0.1, 2.6] | |||
Coetzee, 1992 [45] | 17 | RR | 1.00 (ref) | 0.73 [0.2, 2.8] | |||||
McDonnell, 1993 [46] | 40 | OR | 0.79 [0.1, 7.6] | 1.00 (ref) | 1.16 [0.4, 3.4] | ||||
Patel, 1994 [65] | 7 | RR | 0.00 | 3.6[0.4,29.3] | 1.72[0.1, 25.9] | 1.00 (ref) | |||
Lee, 1994 [47] | 6 | RR | 2.50 [0.4, 15.4] | 1.00 (ref) | 0.00 | ||||
Sutcliffe, 1995 [66] | 82 | RR | Â | Â | Â | 1.00 (ref) | 0.28 [0.2, 0.4] | ||
Kaninda, 1995 [48] | 1295 | RR | 2.27 [1.5, 3.3] | 1.00 (ref) | |||||
Kotb, 1995 [49] | 230 | OR | Â | 2.69[1.9,3.9] | 1.00 (ref) | ||||
Hennessey, 1996 [50] | 167 | RR | 0.91 [0.2, 3.7] | 1.30 [0.8, 2.1] | 1.00 (ref) | 1.08 [0.6, 1.9] | |||
John, 1999 [51] | 67 | RR | 2.01 [0.8, 5.4] | 1.00 (ref) | |||||
B. TWO-DOSE ANALYSIS B-1. VACCINE EFFECTIVENESS [95% Confidence Intervals] | |||||||||
Author, year of epidemic (ref) | Casesa | Â | Age at first vaccination | ||||||
< 9 | 9 | 10–11 | 12 | 13–14 | 15 | > 15 | |||
McCombie, 1985 [36] | 22 | Â | 63.3% [0, 88] | 55.1% [0, 89] | 37.6% [0, 79] | ||||
Roberston, 1986 [38] | 4 |  | 72.2% [0, 96] | 100% faf[−] | |||||
Hersh, 1987 [41] | 4 |  | 88.9% [12, 99] | 100% [−] | |||||
De Serres, 2011 [67]d | 52 | Â | Â | 93.0% [90, 95] | 94.7% [90, 97] | 97.5% [94, 99] | |||
B-2. MEASLES RISK RATIO / ODDS RATIO [95% Confidence Intervals] | |||||||||
Author, year of epidemic (ref) | Casesa | RR/ORb | Age at first vaccination | ||||||
< 9 | 9 | 10–11 | 12 | 13–14 | 15 | > 15 | |||
McCombie, 1985 [36] | 22 | RR | 0.82 [0.2, 3.2] | 1.00 (ref) | 1.39 [0.4, 5.3] | ||||
Paunio 1988 [10] | 153c | OR | 1.00 (ref) | 0.29 [0.04, 2.0] | |||||
De Serres, 1990 [64] | 28 | OR | Â | Â | 3.48 [1.4, 8.4] | 1.00 (ref) | 1.27 [0.4, 4.0] | ||
Defay, 2011 [11] | 99 | OR | Â | Â | Â | 1.00 (ref) | 1.04 [0.7, 1.7] | 0.00 | 0.17[0.04,0.7] |